Oxford Drug Design has been mentioned in an article entitled "Countdown to the last antibiotic" in the March edition of Chemistry World.
ODD scientists and collaborators have published a research paper describing the discovery of a new class of aminoacyl-tRNA synthetase inhibitors, N-Leucinyl benzenesulfonamides.
Dr. Michael Charlton presented a review of literature analyses of the physical properties of antibacterial compounds.
Address
Oxford Drug Design
Oxford Centre for Innovation
New Road
Oxford
OX1 1BY
Contacts
Email: contactus@oxforddrugdesign.com
Phone: +44 (0) 1865 261 468